1. Home
  2. DSX vs NMRA Comparison

DSX vs NMRA Comparison

Compare DSX & NMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Diana Shipping inc. common stock

DSX

Diana Shipping inc. common stock

N/A

Current Price

$2.39

Market Cap

273.7M

ML Signal

N/A

Logo Neumora Therapeutics Inc.

NMRA

Neumora Therapeutics Inc.

N/A

Current Price

$1.68

Market Cap

302.0M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
DSX
NMRA
Founded
1999
2019
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
273.7M
302.0M
IPO Year
2005
2023

Fundamental Metrics

Financial Performance
Metric
DSX
NMRA
Price
$2.39
$1.68
Analyst Decision
Buy
Analyst Count
0
8
Target Price
N/A
$7.50
AVG Volume (30 Days)
601.8K
648.3K
Earning Date
05-28-2026
05-07-2026
Dividend Yield
1.62%
N/A
EPS Growth
N/A
5.23
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$14.28
N/A
Revenue Next Year
$4.87
N/A
P/E Ratio
$16.02
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.53
$0.83
52 Week High
$2.92
$3.65

Technical Indicators

Market Signals
Indicator
DSX
NMRA
Relative Strength Index (RSI) 57.66 51.79
Support Level $2.37 $1.50
Resistance Level $2.42 $1.72
Average True Range (ATR) 0.11 0.09
MACD 0.02 0.01
Stochastic Oscillator 55.71 76.00

Price Performance

Historical Comparison
DSX
NMRA

About DSX Diana Shipping inc. common stock

Diana Shipping Inc provides shipping transportation services. The company, through its subsidiaries, operates a fleet of vessels consisting of dry bulk carriers such as Panamax, Kamsarmax, Post-Panamax, Capesize, and Newcastlemax vessels. Using this fleet, the firm provides transportation services for various goods, including coal, iron ore, and grains. It also transports minor bulks, including steel products, cement, and fertilizers, through its dry bulk carrier vessels. The operation of the vessels is the main source of revenue generation; the services provided by the vessels are similar, and all operate under the same economic environment.

About NMRA Neumora Therapeutics Inc.

Neumora Therapeutics Inc is a clinical-stage biopharmaceutical company founded to confront the brain disease crisis by taking a fundamentally different approach to the way treatments for brain diseases are developed. It has scaled its therapeutic pipeline, which currently consists of seven clinical and preclinical neuroscience programs that target novel mechanisms of action for a broad range of underserved neuropsychiatric disorders and neurodegenerative diseases. Its pipeline includes NMRA-140, NMRA-511, NMRA-266, NMRA-M4R, NMRA-NMDA, NMRA-CK1O, NMRA-NLRP3, and NMRA-GCASE. The group's pipeline is building programs for underserved neuropsychiatric disorders and neurodegenerative diseases.

Share on Social Networks: